Revolving Door: DEA's No.2 quits amid reports of consulting work for Big Pharma
Louis Milione’s four years of consulting for Big Pharma preceded his 2021 return to the DEA to serve as Administrator Anne Milgram’s top deputy.
Stay updated with breaking news from Jeff Hauser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Louis Milione’s four years of consulting for Big Pharma preceded his 2021 return to the DEA to serve as Administrator Anne Milgram’s top deputy.
Louis Milione’s four years of consulting for Big Pharma preceded his 2021 return to the DEA to serve as Administrator Anne Milgram’s top deputy, renewing concerns in the agency and beyond about the revolving door between government and industry and its potential impact on the DEA’s mission to police drug companies.
Louis Milione’s consulting for Big Pharma preceded his 2021 return to the DEA, renewing concerns about the revolving door between government and industry.
Milione initially left the DEA in 2017 after a 21-year career that included a two-year stint leading the division that controls the sale of highly addictive narcotics.
Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024